arx201
Recombinant proteinexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2008 (NCT00778518)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SomatotropinSupplementation
GH1 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- arx201
- arx201
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00778518 | Phase 2 | Jul 1, 2008 | Accelsiors, Ambrx, Merck Serono |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Accelsiors | For profit | 1 | 0 | 1 | 2008 |
| Ambrx | For profit | 1 | 1 | 1 | 2008 |
| Merck Serono | For profit | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1